In summary, enhanced inflammasome activation driven by molecular and genetic factors highlights important aspects of fatal COVID-19 in the second wave, highlighting IL-18 and related genetic markers (rs4648090 NFKB1 and rs317155 NOX4) as molecules of key interest for prognostic and therapeutic consideration in future severe respiratory diseases. This evidence concerns the gene IL18 and COVID-19.